Claris Lifesciences will invest Rs 900 crore, which it expects to receive as part of divestment of 80 percent stake in its infusion business, on various initiatives, including growth of business and pre payment of company's debt.
Last week, the Ahmedabad-based sterile injectables pharmaceutical firm had divested 80 percent stake in its infusion business for a total consideration of Rs 1,050 crore and has entered into a tripartite joint venture with two Japanese firms for the same
No comments:
Post a Comment